血红素氧合酶1的生物学特性及其在冠心病防治中的作用
DOI:
作者:
作者单位:

(泸州医学院附属医院心内科,四川省泸州市 646000)

作者简介:

李谌,硕士研究生,研究方向为介入心脏病学,E-mail为465464814@qq.com。

通讯作者:

基金项目:


The Biological Property of Heme Oxygenase-1 and Its Preventive and Therapeutical Effects in Coronary Heart Disease
Author:
Affiliation:

Department of Cardiology, The Affiliated Hospital of Luzhou Medical College, Luzhou, Sichuan 646000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    红素氧合酶1(HO-1)是一种热休克蛋白,它也是血红素降解过程中的限速酶。HO-1能将具有氧化性质的血红素分解生成具有抗氧化性质的胆红素和抗炎症作用的CO而发挥抗炎症与抗氧化应激等细胞保护功能。鉴于包括动脉粥样硬化、PCI术后再狭窄、心肌梗死在内的冠心病都与活性氧诱导的氧化应激损伤及炎症密切相关,近年已有大量研究证明HO-1在阻止动脉粥样硬化、PCI术后再狭窄及改善心肌梗死预后等方面均能起到重要作用,预示HO-1有望成为冠心病防治的新靶点。

    Abstract:

    Heme oxygenase-1 (HO-1), a stress response protein, is the rate-limiting enzyme in the metabolism of free heme. HO-1 could serve a cytoprotective function by degrading the oxidant heme and generating the antioxidant bilirubin and anti-inflammatory molecule carbon monoxide. Coronary artery diseases including atherosclerosis, myocardial infarction, and restenosis after percutaneous coronary intervention are all associated with reactive oxygen species-induced oxidative stress injury and inflammation. Numerous studies have recently demonstrated HO-1 plays an important function in preventing atherosclerosis, restenosis and improving the myocardial infarction prognosis. HO-1 might be identified as a promising therapeutic target in the prevention and treatment of coronary heart disease.

    参考文献
    相似文献
    引证文献
引用本文

李谌,黄维义.血红素氧合酶1的生物学特性及其在冠心病防治中的作用[J].中国动脉硬化杂志,2016,24(1):92~96.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2015-04-07
  • 最后修改日期:2015-10-31
  • 录用日期:
  • 在线发布日期: 2018-11-19